The Alzheimer's disease plasma proteome
These preliminary findings warrant further study of the plasma proteome in AD and is a first step in defining a blood-based biomarker tool for detection of underlying pathobiological features that are AD/ADRD specific. This will help guide precision medicine therapeutic strategies in AD/ADRD.
Authors
- Lavanya Jain (ORCID: https://orcid.org/0000-0003-0454-5019)
- Lynn M. Bekris (ORCID: https://orcid.org/0000-0002-2747-7672)
- Maria Khrestian (ORCID: https://orcid.org/0000-0002-1621-4711)
- Elizabeth D. Tuason
- James B Leverenz
Institutions
- Cleveland Clinic (US)
- University of Washington (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_106618
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00